To register for the Summit, please provide the details below. We will send you a registration form in return. Please fill out, print, sign, and send back the registration form to [firstname.lastname@example.org], to successfully register. Upon receiving the registration form, we will send you an invoice for payment.
To request an agenda for this Summit, please complete the details below. We will send an agenda to you via email.
To buy a documentation package for this Summit, please complete the details below. Upon receiving this form we will send an invoice for the documentation package. The cost for the documentation package is‚ €500. Upon successfully receiving payment, we will send you the documentation package.
We will contact you shortly
Budapester Str. 2, 10787
This premier B2B event will enable the participants to explore strategies for overcoming scientific, regulatory and legal challenges in the development and commercialization of biosimilars through technical case studies and practical advice from leading biosimilar and regulatory players.
Chief Executives, Executive Directors, VPs, Department Heads, Team Leaders and Managers from:
- Biologics/Biotechnology/ Biogenerics
- Market Strategy
- Regulatory Affairs
- Preclinical and Clinical Development
- Regulatory Strategy
- Pricing and Reimbursement
- Quality Affairs / Quality Control
- Commercial Affairs
- Biopharmaceuticals / Biotherapeutics
- Portfolio Development
- Regulatory Compliance
- New Product Development
- Clinical Immunology
- Business Development
- Marketing & Sales
- The European Biosimilar landscape, what does the future hold: challenges & expectations
- The commercial game and how to play commercial strategy to increase market uptake
- Forecasting biosimilar product portfolios and effectively planning and realigning business strategies for future changes
- Facilitating the acceptance and increasing the uptake of biosimilars
- The experience exchange: developing and introducing biosimilars to new markets
- Overview of Global R&D and regulatory landscape
Executive Director, Biosimilars Development – Scientific Affairs
Director CMC Expert and Tech RA
Boehringer Ingelheim Pharma GmbH & Co. KG
Director Portfolio Management & Strategy – Biosimilars
3rd Annual Biosimilars Summit